1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide

C121H117N45O2 — CID 160638738

IUPAC1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide
SMILESCC(=O)Nc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CCc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1cc(Cn2ncc3ncc(Nc4n[nH]c5ccccc45)cc32)no1.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4nccnc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.c1ccc2c(Nc3cnc4cnn(CC5CCC5)c4c3)n[nH]c2c1
InChIInChI=1S/C18H15N7O.3C18H18N6.C17H17N7.C16H15N7O.C16H16N6/c1-11-6-13(24-26-11)10-25-17-7-12(8-19-16(17)9-20-25)21-18-14-4-2-3-5-15(14)22-23-18;1-18(7-8-18)16-12-6-5-11(10-14(12)24(2)23-16)20-17-15-13(21-22-17)4-3-9-19-15;1-18(7-8-18)15-12-6-5-11(10-14(12)24(2)23-15)20-17-13-4-3-9-19-16(13)21-22-17;1-2-7-15-14(6-1)18(23-22-15)21-13-8-17-16(19-9-13)10-20-24(17)11-12-4-3-5-12;1-17(5-6-17)14-11-4-3-10(9-12(11)24(2)23-14)20-16-13-15(21-22-16)19-8-7-18-13;1-9(24)18-15-11-6-5-10(8-13(11)23(2)22-15)19-16-14-12(20-21-16)4-3-7-17-14;1-3-12-11-7-6-10(9-14(11)22(2)21-12)18-16-15-13(19-20-16)5-4-8-17-15/h2-9H,10H2,1H3,(H2,21,22,23);3-6,9-10H,7-8H2,1-2H3,(H2,20,21,22);3-6,9-10H,7-8H2,1-2H3,(H2,19,20,21,22);1-2,6-10,12H,3-5,11H2,(H2,21,22,23);3-4,7-9H,5-6H2,1-2H3,(H2,19,20,21,22);3-8H,1-2H3,(H,18,22,24)(H2,19,20,21);4-9H,3H2,1-2H3,(H2,18,19,20)
InChIKeyRIWQZNXQDBDDLJ-UHFFFAOYSA-N
MW2233.58 g/mol
LogP23.26
Rot. Bonds23

About 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide

1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide (PubChem CID 160638738) has the molecular formula C121H117N45O2 and a molecular weight of 2233.58 g/mol. Its IUPAC name is 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide.

Molecular Properties

Compound Name1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide
PubChem CID160638738
Molecular FormulaC121H117N45O2
Molecular Weight2233.58 g/mol
Exact Mass2232.04
IUPAC Name1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide
SMILESCC(=O)Nc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CCc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1cc(Cn2ncc3ncc(Nc4n[nH]c5ccccc45)cc32)no1.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4nccnc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.c1ccc2c(Nc3cnc4cnn(CC5CCC5)c4c3)n[nH]c2c1
InChIInChI=1S/C18H15N7O.3C18H18N6.C17H17N7.C16H15N7O.C16H16N6/c1-11-6-13(24-26-11)10-25-17-7-12(8-19-16(17)9-20-25)21-18-14-4-2-3-5-15(14)22-23-18;1-18(7-8-18)16-12-6-5-11(10-14(12)24(2)23-16)20-17-15-13(21-22-17)4-3-9-19-15;1-18(7-8-18)15-12-6-5-11(10-14(12)24(2)23-15)20-17-13-4-3-9-19-16(13)21-22-17;1-2-7-15-14(6-1)18(23-22-15)21-13-8-17-16(19-9-13)10-20-24(17)11-12-4-3-5-12;1-17(5-6-17)14-11-4-3-10(9-12(11)24(2)23-14)20-16-13-15(21-22-16)19-8-7-18-13;1-9(24)18-15-11-6-5-10(8-13(11)23(2)22-15)19-16-14-12(20-21-16)4-3-7-17-14;1-3-12-11-7-6-10(9-14(11)22(2)21-12)18-16-15-13(19-20-16)5-4-8-17-15/h2-9H,10H2,1H3,(H2,21,22,23);3-6,9-10H,7-8H2,1-2H3,(H2,20,21,22);3-6,9-10H,7-8H2,1-2H3,(H2,19,20,21,22);1-2,6-10,12H,3-5,11H2,(H2,21,22,23);3-4,7-9H,5-6H2,1-2H3,(H2,19,20,21,22);3-8H,1-2H3,(H,18,22,24)(H2,19,20,21);4-9H,3H2,1-2H3,(H2,18,19,20)
InChIKeyRIWQZNXQDBDDLJ-UHFFFAOYSA-N
XLogP23.26
TPSA567.96 Ų
H-Bond Donors15
H-Bond Acceptors39
Rotatable Bonds23
Heavy Atoms168
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002233.58
LogP ≤ 523.26
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1039

Analyze 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide?
The IUPAC name of 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide (CID 160638738) is 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide.
What is the SMILES notation for 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide?
The canonical SMILES for 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide is CC(=O)Nc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CCc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1cc(Cn2ncc3ncc(Nc4n[nH]c5ccccc45)cc32)no1.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3[nH]nc4nccnc34)cc21.Cn1nc(C2(C)CC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.c1ccc2c(Nc3cnc4cnn(CC5CCC5)c4c3)n[nH]c2c1.
What is the InChIKey of 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide?
The InChIKey is RIWQZNXQDBDDLJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15N7O.3C18H18N6.C17H17N7.C16H15N7O.C16H16N6/c1-11-6-13(24-26-11)10-25-17-7-12(8-19-16(17)9-20-25)21-18-14-4-2-3-5-15(14)22-23-18;1-18(7-8-18)16-12-6-5-11(10-14(12)24(2)23-16)20-17-15-13(21-22-17)4-3-9-19-15;1-18(7-8-18)15-12-6-5-11(10-14(12)24(2)23-15)20-17-13-4-3-9-19-16(13)21-22-17;1-2-7-15-14(6-1)18(23-22-15)21-13-8-17-16(19-9-13)10-20-24(17)11-12-4-3-5-12;1-17(5-6-17)14-11-4-3-10(9-12(11)24(2)23-14)20-16-13-15(21-22-16)19-8-7-18-13;1-9(24)18-15-11-6-5-10(8-13(11)23(2)22-15)19-16-14-12(20-21-16)4-3-7-17-14;1-3-12-11-7-6-10(9-14(11)22(2)21-12)18-16-15-13(19-20-16)5-4-8-17-15/h2-9H,10H2,1H3,(H2,21,22,23);3-6,9-10H,7-8H2,1-2H3,(H2,20,21,22);3-6,9-10H,7-8H2,1-2H3,(H2,19,20,21,22);1-2,6-10,12H,3-5,11H2,(H2,21,22,23);3-4,7-9H,5-6H2,1-2H3,(H2,19,20,21,22);3-8H,1-2H3,(H,18,22,24)(H2,19,20,21);4-9H,3H2,1-2H3,(H2,18,19,20).
What are the key properties of 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide?
1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide has a molecular weight of 2233.58 g/mol, XLogP of 23.26, 23 rotatable bonds, 15 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(cyclobutylmethyl)-N-(1H-indazol-3-yl)pyrazolo[4,5-b]pyridin-6-amine;N-(3-ethyl-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1H-indazol-3-yl)-1-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrazolo[4,5-b]pyridin-6-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyrazin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-(1-methylcyclopropyl)indazol-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]acetamide is sourced from PubChem (CID 160638738), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).